PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Big-data longevity specialist boosts HonorHealth Research Institute’s efforts to help patients lead longer, more productive lives

Dr. Schork joins the Research Institute’s new Center for Translational Science, emphasizing new technologies to intercept disease before symptoms even appear

2025-08-14
(Press-News.org) SCOTTSDALE, Ariz. — Aug.  14, 2025 — Nicholas J. Schork, Ph.D., an international authority on human longevity and health maintenance, has joined HonorHealth Research Institute as Research Director of Longevity, Prevention and Interception.

Dr. Schork heads a unique laboratory that is part of the Research Institute’s newly created Center for Translational Science, and his appointment is part of a significant push on the part of the Institute to expand its collaborations and the realm of precision medicine possibilities; providing specific answers to individual patients with rare or difficult to treat diseases.

“It’s all about optimizing people’s health,” said Dr. Schork, who has trained and worked at some of the nation’s prominent health research facilities.

“Disease is not like an off and on switch; one day you don’t have disease and the next day you magically do have disease. There are processes that unfold over time that contribute to disease or reflect the pathobiology behind the disease,” he said. “Research focusing on interception tries to understand those processes to the point where one can intervene on them, rather than the overt manifestations of the disease.”

How medical interception works

For example, before treating a patient with some type of medication once they develop a specific cancer, physicians in the future might use new high-tech monitoring of a person’s genome or some type of bodily fluid such as blood, saliva or even cerebral spinal fluid to find biomarkers that would indicate early on who might be at risk of cancer.

Such advanced interception warnings also might be attained through the use of wearable devices, imaging protocols – or anything that might provide more frequent monitoring. The physician then might recommend specific actions or medications an individual might take to avoid cancer altogether before it actually occurs and puts their overall health at risk.

Dr. Schork said he also will employ the use of Artificial Intelligence to interrogate large electronic health records with billions of points of data to synthesize complex information and offer recommendations based on identifying patterns invisible to human clinicians.

“Early AI evaluations show the potential to improve diagnostic accuracy, reduce errors, and personalize care pathways, provided they are validated in rigorous clinical settings,” he said, pointing to the need for clinical efforts to bolster translational discoveries, and translational science to be practiced with patients in the clinical settings.

HonorHealth leadership enthusiastic

In welcoming Dr. Schork and his expertise to HonorHealth, Michael Gordon, M.D., FASCO, Medical Director of the Research Institute, said: “Ultimately, it’s all about living longer, living better, reducing the risk of disease and promoting longevity. We want to emphasize prevention and interception — whether it's intercepting in the evolution of cardiovascular disease or intercepting in the evolution of cancer — we want to find more and more sensitive ways to diagnose disease earlier; to intervene before people develop a symptomatic disorder that compromises their function; their ability to live.”

Mark Slater, Ph.D., CEO of the Research Institute, and Vice President of Research for HonorHealth, said Dr. Schork brings with him a wealth of collaborators and facilitators from across the nation and around the world, which among other things will enhance the Institute’s partnership with Arizona State University’s new School of Medicine and Advanced Medical Engineering.

“Nik is a brilliant mind who has really been at the forefront of developing new innovations and technologies,” Dr. Slater said. “He is a terrific data scientist, and a person in the digital and informatics space who has brought together the basic and translational science into the clinical world across a number of different diseases.”

Sunil Sharma, M.D., MBA, Director of the Center for Translational Science, said, “I have known Dr. Schork for several years now. He is a true renaissance man and I deeply value his unique investigational abilities, scientific rigor and imagination. In his new role, working alongside me at the Center, his computational genius will be a game-changing force for innovation at our Research Institute.”

Dr. Schork’s research background

Most recently, Dr. Schork held the positions of Distinguished Professor and Director of the Division of Clinical Genomics and Therapeutics at Phoenix’s Translational Genomics Research Institute (TGen), a frequent clinical trial collaborator with the Institute.

He also held the titles of: Adjunct Professor of Population Sciences as well as Molecular and Cellular Biology at City of Hope; Adjunct Professor of Psychiatry and Biostatistics at the University of California San Diego; and Adjunct Professor of Integrative Structural and Computational Biology at Scripps Research Institute.
 
Prior to those positions, Dr. Schork was Professor and Director of Human Biology at the J. Craig Venter Institute; Professor, Molecular and Experimental Medicine, at Scripps Research, and Director of Bioinformatics and Biostatistics for the Scripps Translational Science Institute. Dr. Schork has also held faculty appointments at Case Western Reserve University and Harvard University.

Dr. Schork has published over 600 articles in many areas of biomedical and translation science, including articles detailing novel methodologies and applications leveraging integrated approaches to disease diagnosis, treatment, and prevention, as well as clinical trials design. He also has a long history of collaborative and consortium-related research in which he has contributed analysis methodology and applied data analysis expertise.

# # #

About the HonorHealth Research Institute
HonorHealth Research Institute is an international destination that is at the forefront of providing patients with a better quality of life through its clinical trials and innovative treatment options. Headquartered in Scottsdale, Arizona, the institute’s team of physicians and researchers collaborate with experts from across the nation to offer life-changing therapies, drugs and devices. At HonorHealth Research Institute, patients have access to tomorrow’s health innovations, today. Learn more at: HonorHealth.com/research.

For more about HonorHealth Research Institute clinical trials: call 833-354-6667; or email clinicaltrials@HonorHealth.com.

END



ELSE PRESS RELEASES FROM THIS DATE:

Helping others shown to slow cognitive decline

2025-08-13
In the latest evidence that meaningful social connections bolster health, a team from The University of Texas at Austin and University of Massachusetts Boston has found that regular time spent helping outside the home significantly slows cognitive decline in middle-age and older adults. The new study of more than 30,000 adults in the U.S. looking at individuals over two decades found that the rate of cognitive decline associated with aging fell by 15%-20% for people who formally volunteer their services or who help in more informal ways with neighbors, family or friends outside the home on a regular basis. This cognitive benefit was consistently observed when individuals ...

Youth violence prevention program shown to reduce arrests by up to 75%

2025-08-13
A CU Boulder-led initiative to reduce youth violence in hard-hit Denver neighborhoods was associated with a 75% decline in arrests for murder, assault, robbery and other youth crimes in recent years, new research shows. “We now have concrete data to show that when communities come together and mobilize, we can prevent youth violence, even in urban settings with a very high burden,” said senior author Beverly Kingston, director of CU’s Center for the Study and Prevention of Violence (CSPV).  The study, published ...

ADHD medication linked to reduced risk of suicide, drug abuse, transport accidents and criminal behaviour

2025-08-13
Drug treatment for people with newly diagnosed attention deficit hyperactivity disorder (ADHD) is associated with significantly reduced risks of suicidal behaviours, substance misuse, transport accidents, and criminality, finds a study published by The BMJ today.  The researchers say this is the first study of its kind to show beneficial effects of ADHD drug treatment on broader clinical outcomes for all ADHD patients and should help inform clinical practice. ADHD affects around 5% of children and 2.5% of adults worldwide and is associated with adverse outcomes including suicidal behaviours, substance ...

AI Chatbots can be exploited to extract more personal information

2025-08-13
AI Chatbots that provide human-like interactions are used by millions of people every day, however new research has revealed that they can be easily manipulated to encourage users to reveal even more personal information. Intentionally malicious AI chatbots can influence users to reveal up to 12.5 times more of their personal information, a new study by King’s College London has found. For the first time, the research shows how conversational AI (CAIs) programmed to deliberately extract data can successfully encourage users to reveal private information using known prompt techniques and psychological ...

Clinical trial shows newborns with spinal muscular atrophy (SMA) can start treatment at birth

2025-08-13
(MEMPHIS, Tenn. – August 13, 2025) Spinal muscular atrophy (SMA) is a rare genetic condition that causes progressive muscle weakness, which, when untreated, prevents infants with the most severe form from gaining motor development — never gaining the ability to sit — and typically leads to death before 2 years of age. The oral drug risdiplam benefits symptomatic patients with improved motor function and increased survival, but had only been Food and Drug Administration–approved for use in patients aged 2 months and older. An international consortium, co-led by Richard Finkel, MD, of St. ...

Broad COVID-19 vaccination makes economic sense, especially for older adults, study finds

2025-08-13
As the nation gears up for the rollout of an updated COVID-19 vaccine, a new study shows the economic benefits of continued broad vaccination in adults. In fact, the country would ultimately save more money that it would spend on vaccinating every person over age 65 with a single dose of an updated mRNA vaccine against coronavirus, the study concludes. That’s because of the power of the vaccine to prevent deaths, hospitalizations, short- and long-term illness and lost productivity such as lost workdays in this age group, the researchers report based on a computer model. The model focused on people without immunocompromising conditions or medications. Meanwhile, ...

People who move to more walkable cities do, in fact, walk significantly more

2025-08-13
Study after study shows that walking is very good for those who are able, and generally more is better. A 2023 study found that even 4,000 steps a day improves all-cause mortality risk. (The U.S average is 4,000 to 5,000.) For each 1,000 extra daily steps, risk decreased by 15%. Walk Scores have been used since 2007 to quantify how quickly people can typically walk to amenities like grocery stores and schools in an area. Cities are assigned scores from 0 to 100; for instance, Seattle’s 74 means it’s “very walkable.” It may seem self-evident that in cities ...

Zombie cancer cells give cold shoulder to chemotherapy

2025-08-13
Cancer is the leading cause of disease-related death in childhood. This is in part due to cancer-associated genes called oncogenes that can be found far from chromosomes in cell nuclei on ring-shaped DNA inside tumor cells. Circular extra-chromosomal DNA elements (ecDNA) are pieces of DNA that have broken off normal chromosomes and then been wrongly stitched together by DNA repair mechanisms. This phenomenon leads to circular DNA elements floating around in a cancer cell. “We have shown that these ecDNAs are ...

New bioimaging device holds potential for eye and heart condition detection

2025-08-13
If you’ve been to a routine eye exam at the optometrist’s office, chances are you’ve had to place your chin and forehead up close to a bioimaging device.  It’s known as optical coherence tomography (OCT), and it’s widely used in eye clinics around the world. OCT uses light waves to take high-resolution, cross-sectional images of the retina in a non-invasive manner. These images can be essential for diagnosing and monitoring eye conditions.  In any bioimaging—either retinal or in-vivo imaging that takes place inside the human body—devices ...

MSU study finds tiny microbes shape brain development

2025-08-13
MSU has a satellite uplink/LTN TV studio and Comrex line for radio interviews upon request.  Why this matters: Microbes, or microorganisms, are all around us and play an important role in bodily functions. MSU researchers found that microbes can also impact brain development. This work is significant because modern obstetric practices like peripartum antibiotic use and Cesarean delivery disturb the microbiome of mothers and newborns. EAST LANSING, Mich. – New research from Michigan State University finds that microbes play an important role in shaping early brain development, specifically in a key brain region that controls stress, social behavior, and vital body ...

LAST 30 PRESS RELEASES:

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

Acupuncture may help improve perceived breast cancer-related cognitive difficulties over usual care

Nerve block may reduce opioid use in infants undergoing cleft palate surgery

CRISPR primes goldenberry for fruit bowl fame

Mass General Brigham announces new AI company to accelerate clinical trial screening and patient recruitment

Fat tissue around the heart may contribute to greater heart injury after a heart attack

Jeonbuk National University researcher proposes a proposing a two-stage decision-making framework of lithium governance in Latin America

Chromatin accessibility maps reveal how stem cells drive myelodysplastic progression

Cartilaginous cells regulate growth and blood vessel formation in bones

Plant hormone allows lifelong control of proteins in living animal for first time

[Press-News.org] Big-data longevity specialist boosts HonorHealth Research Institute’s efforts to help patients lead longer, more productive lives
Dr. Schork joins the Research Institute’s new Center for Translational Science, emphasizing new technologies to intercept disease before symptoms even appear